Goto

Collaborating Authors

 different risk-return profile


How a portfolio approach to AI helps your ROI

#artificialintelligence

Instead of computing the success or failure of AI initiatives on a project-by-project basis, companies using the portfolio approach compute the ROI for all their AI initiatives. A portfolio approach works in other areas of business, and the same principles apply here. Take a look at three relevant examples and the lessons for AI. In the pharmaceutical world, developing a new drug takes an average of at least ten years and costs over $2.6 billion. Literally thousands and even millions of molecules and investigative drugs are studied during the initial drug discovery and preclinical trial phases of the R&D process.